Wells Fargo’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11M | Sell |
21,524
-39,548
| -65% | -$2.01M | ﹤0.01% | 3681 |
|
|
2025
Q4 | $3.04M | Buy |
61,072
+19,306
| +46% | +$939K | ﹤0.01% | 3112 |
|
|
2025
Q3 | $2M | Sell |
41,766
-28,470
| -41% | -$1.15M | ﹤0.01% | 3303 |
|
|
2025
Q2 | $2.21M | Buy |
70,236
+5,546
| +9% | +$178K | ﹤0.01% | 3148 |
|
|
2025
Q1 | $2.12M | Buy |
64,690
+1,453
| +2% | +$51.5K | ﹤0.01% | 3123 |
|
|
2024
Q4 | $2.29M | Buy |
63,237
+7,961
| +14% | +$280K | ﹤0.01% | 3104 |
|
|
2024
Q3 | $1.72M | Buy |
55,276
+31
| +0.1% | +$968 | ﹤0.01% | 3152 |
|
|
2024
Q2 | $1.48M | Buy |
55,245
+6,444
| +13% | +$187K | ﹤0.01% | 3217 |
|
|
2024
Q1 | $1.66M | Buy |
48,801
+2,327
| +5% | +$69.3K | ﹤0.01% | 3120 |
|
|
2023
Q4 | $1.34M | Sell |
46,474
-549
| -1% | -$14.6K | ﹤0.01% | 3223 |
|
|
2023
Q3 | $1.3M | Sell |
47,023
-14,771
| -24% | -$450K | ﹤0.01% | 3135 |
|
|
2023
Q2 | $1.86M | Buy |
61,794
+10,071
| +19% | +$352K | ﹤0.01% | 2975 |
|
|
2023
Q1 | $1.87M | Buy |
51,723
+10,090
| +24% | +$388K | ﹤0.01% | 2920 |
|
|
2022
Q4 | $1.49M | Sell |
41,633
-7,825
| -16% | -$272K | ﹤0.01% | 2987 |
|
|
2022
Q3 | $1.67M | Sell |
49,458
-3,806
| -7% | -$124K | ﹤0.01% | 2871 |
|
|
2022
Q2 | $1.54M | Sell |
53,264
-53,174
| -50% | -$1.52M | ﹤0.01% | 2990 |
|
|
2022
Q1 | $3.44M | Sell |
106,438
-12,328
| -10% | -$378K | ﹤0.01% | 2782 |
|
|
2021
Q4 | $3.46M | Sell |
118,766
-23,641
| -17% | -$717K | ﹤0.01% | 2942 |
|
|
2021
Q3 | $3.8M | Buy |
142,407
+17,296
| +14% | +$464K | ﹤0.01% | 3096 |
|
|
2021
Q2 | $3.85M | Sell |
125,111
-87,065
| -41% | -$2.67M | ﹤0.01% | 3098 |
|
|
2021
Q1 | $5.55M | Buy |
212,176
+78,857
| +59% | +$2.21M | ﹤0.01% | 2746 |
|
|
2020
Q4 | $3.35M | Sell |
133,319
-7,248
| -5% | -$156K | ﹤0.01% | 3084 |
|
|
2020
Q3 | $2.93M | Buy |
140,567
+11,916
| +9% | +$270K | ﹤0.01% | 3001 |
|
|
2020
Q2 | $3.06M | Buy |
128,651
+9,622
| +8% | +$213K | ﹤0.01% | 2917 |
|
|
2020
Q1 | $2.14M | Sell |
119,029
-39,725
| -25% | -$835K | ﹤0.01% | 2940 |
|
|
2019
Q4 | $3.77M | Sell |
158,754
-47,897
| -23% | -$1.16M | ﹤0.01% | 2817 |
|
|
2019
Q3 | $5.68M | Sell |
206,651
-71,326
| -26% | -$2.11M | ﹤0.01% | 2432 |
|
|
2019
Q2 | $9.2M | Sell |
277,977
-92,033
| -25% | -$3.15M | ﹤0.01% | 2028 |
|
|
2019
Q1 | $13M | Sell |
370,010
-240,625
| -39% | -$8.95M | ﹤0.01% | 1748 |
|
|
2018
Q4 | $20.3M | Sell |
610,635
-183,048
| -23% | -$7.87M | 0.01% | 1365 |
|
|
2018
Q3 | $40M | Sell |
793,683
-163,527
| -17% | -$8.08M | 0.01% | 1073 |
|
|
2018
Q2 | $57.3M | Buy |
957,210
+61,100
| +7% | +$3.17M | 0.02% | 832 |
|
|
2018
Q1 | $41M | Buy |
896,110
+140,688
| +19% | +$5.87M | 0.01% | 1011 |
|
|
2017
Q4 | $30.1M | Buy |
755,422
+139,838
| +23% | +$5.53M | 0.01% | 1196 |
|
|
2017
Q3 | $24.6M | Sell |
615,584
-45,691
| -7% | -$1.98M | 0.01% | 1281 |
|
|
2017
Q2 | $28.5M | Buy |
661,275
+148,266
| +29% | +$5.28M | 0.01% | 1170 |
|
|
2017
Q1 | $16.1M | Buy |
513,009
+4,241
| +0.8% | +$114K | 0.01% | 1526 |
|
|
2016
Q4 | $12.8M | Buy |
508,768
+34,692
| +7% | +$775K | ﹤0.01% | 1676 |
|
|
2016
Q3 | $11.7M | Sell |
474,076
-65,028
| -12% | -$1.47M | ﹤0.01% | 1656 |
|
|
2016
Q2 | $11M | Sell |
539,104
-18,730
| -3% | -$332K | ﹤0.01% | 1757 |
|
|
2016
Q1 | $8.51M | Buy |
557,834
+41,050
| +8% | +$536K | ﹤0.01% | 1933 |
|
|
2015
Q4 | $6.95M | Buy |
516,784
+57,358
| +12% | +$887K | ﹤0.01% | 2113 |
|
|
2015
Q3 | $6.45M | Sell |
459,426
-18,416
| -4% | -$342K | ﹤0.01% | 2132 |
|
|
2015
Q2 | $8.11M | Buy |
477,842
+116,528
| +32% | +$1.66M | ﹤0.01% | 2068 |
|
|
2015
Q1 | $4.37M | Buy |
361,314
+43,588
| +14% | +$412K | ﹤0.01% | 2473 |
|
|
2014
Q4 | $2.64M | Buy |
317,726
+316,379
| +23,488% | +$2.66M | ﹤0.01% | 2809 |
|
|
2014
Q3 | $12K | Sell |
1,347
-1,147
| -46% | -$10.4K | ﹤0.01% | 5512 |
|
|
2014
Q2 | $27K | Buy |
+2,494
| New | +$22.2K | ﹤0.01% | 5235 |
|
|
2014
Q1 | – | Sell |
-31
| Closed | – | – | 6064 |
|
|
2013
Q4 | $0 | Buy |
+31
| New | +$217 | ﹤0.01% | 5914 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Wells Fargo's SUPN Position: Q1 2026 in Review
Wells Fargo reduced its Supernus Pharmaceuticals (SUPN) stake by 65% in Q1 2026, selling an estimated $2.01M and leaving 21,524 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3681.
Wells Fargo first reported a position in SUPN in Q4 2013 and has held it in 49 quarters since. The position peaked at $57.3M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Wells Fargo held 21,524 shares of Supernus Pharmaceuticals worth $1.11M as of Q1 2026.
- Wells Fargo sold 39,548 Supernus Pharmaceuticals shares in Q1 2026, an estimated $2.01M.
- Supernus Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3681 holding.
- Wells Fargo first reported a position in Supernus Pharmaceuticals in Q4 2013 and has held it in 49 quarters since.
- Wells Fargo's Supernus Pharmaceuticals position peaked at $57.3M in Q2 2018.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.